These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9814723)

  • 41. Statistics commentary series: Commentary #5--can it work or does it work? The difference between efficacy and effectiveness trials.
    Streiner DL
    J Clin Psychopharmacol; 2014 Dec; 34(6):672-4. PubMed ID: 25275674
    [No Abstract]   [Full Text] [Related]  

  • 42. The challenge of subgroup analyses--reporting without distorting.
    Lagakos SW
    N Engl J Med; 2006 Apr; 354(16):1667-9. PubMed ID: 16625007
    [No Abstract]   [Full Text] [Related]  

  • 43. Appointment of statistical editor and quality of statistics in a small medical journal.
    Lukić IK; Marusić M
    Croat Med J; 2001 Oct; 42(5):500-3. PubMed ID: 11593496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study design, methodology and statistical analyses in the clinical development of sparfloxacin.
    Genevois E; Lelouer V; Vercken JB; Caillon R
    J Antimicrob Chemother; 1996 May; 37 Suppl A():65-72. PubMed ID: 8737126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statistical power and sample size requirements for three level hierarchical cluster randomized trials.
    Heo M; Leon AC
    Biometrics; 2008 Dec; 64(4):1256-62. PubMed ID: 18266889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Count on your beliefs. Bayes--not the P value--measures credence].
    Taube A; Malmquist J
    Lakartidningen; 2001 Jul; 98(28-29):3208-11. PubMed ID: 11496808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data.
    Weinberg JM; Lagakos SW
    Stat Med; 2001 Mar; 20(5):705-31. PubMed ID: 11241572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statistical power in three-arm cluster randomized trials.
    Liu XS
    Eval Health Prof; 2014 Dec; 37(4):470-87. PubMed ID: 23908381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Annals Understanding Clinical Research: Interpreting Results With Large P Values.
    Liao JM; Stack CB; Goodman S
    Ann Intern Med; 2018 Oct; 169(7):485-486. PubMed ID: 30208404
    [No Abstract]   [Full Text] [Related]  

  • 50. Group sequential methods for cluster randomization trials with binary outcomes.
    Zou GY; Donner A; Klar N
    Clin Trials; 2005; 2(6):479-87. PubMed ID: 16422308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Institutional review board approval and publication of human research results.
    Amdur RJ; Biddle C
    JAMA; 1997 Mar; 277(11):909-14. PubMed ID: 9062330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avoid lost discoveries, because of violations of standard assumptions, by using modern robust statistical methods.
    Wilcox R; Carlson M; Azen S; Clark F
    J Clin Epidemiol; 2013 Mar; 66(3):319-29. PubMed ID: 23195918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature.
    Scales CD; Norris RD; Preminger GM; Vieweg J; Peterson BL; Dahm P
    J Urol; 2008 Oct; 180(4):1463-7. PubMed ID: 18710745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of Lowering the P Value Threshold for Statistical Significance From .05 to .005 in Previously Published Randomized Clinical Trials in Major Medical Journals.
    Wayant C; Scott J; Vassar M
    JAMA; 2018 Nov; 320(17):1813-1815. PubMed ID: 30398593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How well do reports of clinical trials in the orthodontic literature comply with the CONSORT statement?
    Flint HE; Harrison JE
    J Orthod; 2010 Dec; 37(4):250-61. PubMed ID: 21186305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CONSORT in China: past development and future direction.
    Song TJ; Leng HF; Zhong LL; Wu TX; Bian ZX
    Trials; 2015 Jun; 16():243. PubMed ID: 26026311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ON THE USE OF NONPARAMETRIC BOUNDS FOR CAUSAL EFFECTS IN NULL RANDOMIZED TRIALS.
    Gabriel EE; Sachs MC
    Am J Epidemiol; 2021 Oct; 190(10):2231. PubMed ID: 34017983
    [No Abstract]   [Full Text] [Related]  

  • 58. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations.
    Bailar JC; Mosteller F
    Ann Intern Med; 1988 Feb; 108(2):266-73. PubMed ID: 3341656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A powerful and robust test statistic for randomization inference in group-randomized trials with matched pairs of groups.
    Zhang K; Traskin M; Small DS
    Biometrics; 2012 Mar; 68(1):75-84. PubMed ID: 21732926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controversies concerning randomization and additivity in clinical trials.
    Senn S
    Stat Med; 2004 Dec; 23(24):3729-53. PubMed ID: 15580598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.